Corient Private Wealth’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
13,944
+8,674
+165% +$1.2M ﹤0.01% 1416
2026
Q1
$698K Sell
5,270
-1,195
-18% -$179K ﹤0.01% 1850
2025
Q4
$1.12M Buy
6,465
+1,953
+43% +$357K ﹤0.01% 1457
2025
Q3
$925K Sell
4,512
-384
-8% -$81.2K ﹤0.01% 1467
2025
Q2
$967K Buy
4,896
+576
+13% +$105K ﹤0.01% 1378
2025
Q1
$748K Sell
4,320
-255
-6% -$53.1K ﹤0.01% 1410
2024
Q4
$1.24M Buy
4,575
+404
+10% +$115K ﹤0.01% 1221
2024
Q3
$1.17M Buy
4,171
+718
+21% +$183K ﹤0.01% 1325
2024
Q2
$852K Buy
3,453
+69
+2% +$15.6K ﹤0.01% 1386
2024
Q1
$847K Sell
3,384
-984
-23% -$234K ﹤0.01% 1367
2023
Q4
$941K Buy
4,368
+2,053
+89% +$434K ﹤0.01% 1311
2023
Q3
$458K Buy
2,315
+795
+52% +$155K ﹤0.01% 1544
2023
Q2
$304K Sell
1,520
-1,932
-56% -$335K ﹤0.01% 1691
2023
Q1
$535K Buy
3,452
+1,467
+74% +$202K ﹤0.01% 1352
2022
Q4
$241K Buy
+1,985
New +$244K ﹤0.01% 1418

Other funds holding MANH

Corient Private Wealth's MANH Position: Q2 2026 in Review

Corient Private Wealth increased its Manhattan Associates (MANH) stake by 165% in Q2 2026, buying an estimated $1.2M and bringing the position to 13,944 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Corient Private Wealth first reported a position in MANH in Q4 2022 and has held it in 15 quarters since. 505 funds tracked by Wall St. Rank hold MANH as of Q2 2026.

  • Corient Private Wealth held 13,944 shares of Manhattan Associates worth $1.94M as of Q2 2026.
  • Corient Private Wealth bought 8,674 Manhattan Associates shares in Q2 2026, an estimated $1.2M.
  • Manhattan Associates made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1416 holding.
  • Corient Private Wealth first reported a position in Manhattan Associates in Q4 2022 and has held it in 15 quarters since.
  • 505 funds tracked by Wall St. Rank held Manhattan Associates as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.